TerminatedPhase 2NCT00424749

Rituxan in Churg Strauss Syndrome With Renal Involvement

Studying Vasculitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fernando Fervenza
Principal Investigator
Fernando C. Fervenza, M.D., Ph.D.
Mayo Clinic
Intervention
Rituximab(drug)
Enrollment
4 enrolled
Eligibility
18 years · All sexes
Timeline
20072009

Study locations (1)

Collaborators

Genentech, Inc. · Biogen · National Center for Research Resources (NCRR)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00424749 on ClinicalTrials.gov

Other trials for Vasculitis

Additional recruiting or active studies for the same condition.

See all trials for Vasculitis

← Back to all trials